ALCLOMETASONE DIPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Alclometasone Dipropionate patents expire, and when can generic versions of Alclometasone Dipropionate launch?
Alclometasone Dipropionate is a drug marketed by Fougera Pharms, Glenmark Pharms Ltd, and Taro. and is included in six NDAs.
The generic ingredient in ALCLOMETASONE DIPROPIONATE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alclometasone Dipropionate
A generic version of ALCLOMETASONE DIPROPIONATE was approved as alclometasone dipropionate by TARO on July 29th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALCLOMETASONE DIPROPIONATE?
- What are the global sales for ALCLOMETASONE DIPROPIONATE?
- What is Average Wholesale Price for ALCLOMETASONE DIPROPIONATE?
Summary for ALCLOMETASONE DIPROPIONATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
Clinical Trials: | 1 |
Patent Applications: | 3,749 |
Drug Prices: | Drug price information for ALCLOMETASONE DIPROPIONATE |
DailyMed Link: | ALCLOMETASONE DIPROPIONATE at DailyMed |
Recent Clinical Trials for ALCLOMETASONE DIPROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 2 |
Pharmacology for ALCLOMETASONE DIPROPIONATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |